Law360
Sunshine Overseas: Transparency Rules For Life Sciences
November 2012
In the wake of the U.S. Physician Payments Sunshine Act (signed into law in March 2010), European, Asian and Australian governmental bodies and trade associations have been rapidly adopting “Sunshine-like” transparency and disclosure requirements applicable to life sciences companies.
Contacts
Capabilities
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Highly Ranked in Chambers USA 2026June 4, 2026Corporate Practice of Medicine Update: California Attorney General Examines the Friendly Professional Corporation ModelJune 3, 2026U.S. Government Finalizes No Surprises Act Independent Dispute Resolution Operations RuleJune 2, 2026Favorable Precision Oncology Advisory Opinion Imposes Limits on Supplemental Reports for PatientsJune 1, 2026Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN DealsMay 29, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
